Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.provenance | CONICET | - |
dc.creator | Sookoian, Silvia Cristina | - |
dc.creator | Pirola, Carlos José | - |
dc.date | 2018-06-22T20:40:28Z | - |
dc.date | 2018-06-22T20:40:28Z | - |
dc.date | 2017-04-13 | - |
dc.date | 2018-06-04T17:01:40Z | - |
dc.date.accessioned | 2019-04-29T15:39:26Z | - |
dc.date.available | 2019-04-29T15:39:26Z | - |
dc.date.issued | 2017-04-13 | - |
dc.identifier | Sookoian, Silvia Cristina; Pirola, Carlos José; Nonalcoholic fatty liver disease: Biomarkers support decisions around pharmacological intervention; John Wiley & Sons Inc; Hepatology (Baltimore, Md.); 65; 4; 13-4-2017; 1417-1419 | - |
dc.identifier | 0270-9139 | - |
dc.identifier | http://hdl.handle.net/11336/49789 | - |
dc.identifier | CONICET Digital | - |
dc.identifier | CONICET | - |
dc.identifier.uri | http://rodna.bn.gov.ar:8080/jspui/handle/bnmm/298733 | - |
dc.description | We read with great interest the article of Ajmera et al. (1) reporting on the relationship between bio- markers and the histological disease spectrum of nonal- coholic fatty liver disease (NAFLD) in a large population of well-characterized patients from the Non- alcoholic Steatohepatitis Clinical Research Network. The researchers found a significant association between circulating levels of total plasminogen activator inhibitor 1 (tPAI1) and the presence of nonalcoholic steatohepa- titis, which was independent of clinical confounding factors. (1) The clinical value of this result should be highlighted, also having important implications for tai- loring pharmacological interventions. | - |
dc.description | Fil: Sookoian, Silvia Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina | - |
dc.description | Fil: Pirola, Carlos José. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina | - |
dc.format | application/pdf | - |
dc.format | application/pdf | - |
dc.language | eng | - |
dc.publisher | John Wiley & Sons Inc | - |
dc.relation | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1002/hep.28866 | - |
dc.relation | info:eu-repo/semantics/altIdentifier/url/https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.28866 | - |
dc.rights | info:eu-repo/semantics/restrictedAccess | - |
dc.rights | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | - |
dc.source | reponame:CONICET Digital (CONICET) | - |
dc.source | instname:Consejo Nacional de Investigaciones Científicas y Técnicas | - |
dc.source | instacron:CONICET | - |
dc.source.uri | http://hdl.handle.net/11336/49789 | - |
dc.subject | NAFLD | - |
dc.subject | NASH | - |
dc.subject | BIOMARKERS | - |
dc.subject | METABOLIC SYNDROME | - |
dc.subject | Medicina Critica y de Emergencia | - |
dc.subject | Medicina Clínica | - |
dc.subject | CIENCIAS MÉDICAS Y DE LA SALUD | - |
dc.title | Nonalcoholic fatty liver disease: Biomarkers support decisions around pharmacological intervention | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.type | info:ar-repo/semantics/articulo | - |
Aparece en las colecciones: | CONICET |
Ficheros en este ítem:
No hay ficheros asociados a este ítem.